These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29534892)

  • 41. Neutralization of toxicological activities of medically-relevant Bothrops snake venoms and relevant toxins by two polyvalent bothropic antivenoms produced in Peru and Brazil.
    Estevao-Costa MI; Gontijo SS; Correia BL; Yarleque A; Vivas-Ruiz D; Rodrigues E; Chávez-Olortegui C; Oliveira LS; Sanchez EF
    Toxicon; 2016 Nov; 122():67-77. PubMed ID: 27641748
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of a new polyspecific antivenom for snakebite envenoming in Sri Lanka: Analysis of its preclinical efficacy as compared to a currently available antivenom.
    Villalta M; Sánchez A; Herrera M; Vargas M; Segura Á; Cerdas M; Estrada R; Gawarammana I; Keyler DE; McWhorter K; Malleappah R; Alape-Girón A; León G; Gutiérrez JM
    Toxicon; 2016 Nov; 122():152-159. PubMed ID: 27720977
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of a chicken-derived antivenom against the taipan snake (Oxyuranus scutellatus) venom and comparison with an equine antivenom.
    Navarro D; Vargas M; Herrera M; Segura Á; Gómez A; Villalta M; Ramírez N; Williams D; Gutiérrez JM; León G
    Toxicon; 2016 Sep; 120():1-8. PubMed ID: 27373994
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of camelid IgG for antivenom development: Serological responses of venom-immunised camels to prepare either monospecific or polyspecific antivenoms for West Africa.
    Cook DA; Owen T; Wagstaff SC; Kinne J; Wernery U; Harrison RA
    Toxicon; 2010 Sep; 56(3):363-72. PubMed ID: 20362604
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-loxoscelic horse serum produced against a recombinant dermonecrotic protein of Brazilian Loxosceles intermedia spider neutralize lethal effects of Loxosceles laeta venom from Peru.
    Duarte CG; Bonilla C; Guimarães G; Machado de Avila RA; Mendes TM; Silva W; Tintaya B; Yarleque A; Chávez-Olórtegui C
    Toxicon; 2015 Jan; 93():37-40. PubMed ID: 25448393
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of immunoturbidimetry to detect venom-antivenom binding using snake venoms.
    O'Leary MA; Maduwage K; Isbister GK
    J Pharmacol Toxicol Methods; 2013; 67(3):177-81. PubMed ID: 23416032
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current technology for the industrial manufacture of snake antivenoms.
    León G; Vargas M; Segura Á; Herrera M; Villalta M; Sánchez A; Solano G; Gómez A; Sánchez M; Estrada R; Gutiérrez JM
    Toxicon; 2018 Sep; 151():63-73. PubMed ID: 29959968
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunological cross-reactivity and neutralization of the principal toxins of Naja sumatrana and related cobra venoms by a Thai polyvalent antivenom (Neuro Polyvalent Snake Antivenom).
    Leong PK; Fung SY; Tan CH; Sim SM; Tan NH
    Acta Trop; 2015 Sep; 149():86-93. PubMed ID: 26026717
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Toxins not neutralized by brown snake antivenom.
    Judge RK; Henry PJ; Mirtschin P; Jelinek G; Wilce JA
    Toxicol Appl Pharmacol; 2006 Jun; 213(2):117-25. PubMed ID: 16256159
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of an antivenom against toxins of Lonomia obliqua caterpillars.
    Da Silva WD; Campos CM; Gonçalves LR; Sousa-e-Silva MC; Higashi HG; Yamagushi IK; Kelen EM
    Toxicon; 1996 Sep; 34(9):1045-9. PubMed ID: 8896196
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of premedication with subcutaneous adrenaline on the pharmacokinetics and immunogenicity of equine whole IgG antivenom in a rabbit model.
    Herrera M; Sánchez M; Machado A; Ramírez N; Vargas M; Villalta M; Sánchez A; Segura Á; Gómez A; Solano G; Gutiérrez JM; León G
    Biomed Pharmacother; 2017 Jun; 90():740-743. PubMed ID: 28419970
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparative study of venomics of Naja naja from India and Sri Lanka, clinical manifestations and antivenomics of an Indian polyspecific antivenom.
    Sintiprungrat K; Watcharatanyatip K; Senevirathne WD; Chaisuriya P; Chokchaichamnankit D; Srisomsap C; Ratanabanangkoon K
    J Proteomics; 2016 Jan; 132():131-43. PubMed ID: 26506536
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Australian taipan (Oxyuranus spp.) envenoming: clinical effects and potential benefits of early antivenom therapy - Australian Snakebite Project (ASP-25).
    Johnston CI; Ryan NM; O'Leary MA; Brown SG; Isbister GK
    Clin Toxicol (Phila); 2017 Feb; 55(2):115-122. PubMed ID: 27903075
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mulga snake (Pseudechis australis) envenoming: a spectrum of myotoxicity, anticoagulant coagulopathy, haemolysis and the role of early antivenom therapy - Australian Snakebite Project (ASP-19).
    Johnston CI; Brown SG; O'Leary MA; Currie BJ; Greenberg R; Taylor M; Barnes C; White J; Isbister GK;
    Clin Toxicol (Phila); 2013 Jun; 51(5):417-24. PubMed ID: 23586640
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel human recombinant antibody fragment capable of neutralizing Mexican scorpion toxins.
    Riaño-Umbarila L; Olamendi-Portugal T; Morelos-Juárez C; Gurrola GB; Possani LD; Becerril B
    Toxicon; 2013 Dec; 76():370-6. PubMed ID: 24067940
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A bispecific nanobody to provide full protection against lethal scorpion envenoming.
    Hmila I; Saerens D; Ben Abderrazek R; Vincke C; Abidi N; Benlasfar Z; Govaert J; El Ayeb M; Bouhaouala-Zahar B; Muyldermans S
    FASEB J; 2010 Sep; 24(9):3479-89. PubMed ID: 20410443
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and cross reactivity of Thai green pit viper antivenom among venoms of Trimeresurus species in Thailand and Japan.
    Pakmanee N; Khow O; Wongtongkam N; Omori-Satoh T; Sitprija V
    J Nat Toxins; 1998 Jun; 7(2):173-83. PubMed ID: 9678190
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Production and preclinical assessment of camelid immunoglobulins against Echis sochureki venom from desert of Rajasthan, India.
    Tanwar PD; Ghorui SK; Kochar SK; Singh R; Patil NV
    Toxicon; 2017 Aug; 134():1-5. PubMed ID: 28528176
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neutralization of four Peruvian Bothrops sp. snake venoms by polyvalent antivenoms produced in Perú and Costa Rica: preclinical assessment.
    Rojas E; Quesada L; Arce V; Lomonte B; Rojas G; Gutiérrez JM
    Acta Trop; 2005 Jan; 93(1):85-95. PubMed ID: 15589801
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neutralization of the pharmacological effects of Cobra and Krait venoms by chicken egg yolk antibodies.
    Meenatchisundaram S; Parameswari G; Michael A; Ramalingam S
    Toxicon; 2008 Aug; 52(2):221-7. PubMed ID: 18590753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.